CEO Today Africa Awards

www.ceotodaymagazine.com 28 CEO Today Africa Awards 2019 ALGERIa RACHID KERRAR CEO Beker Laboratories FIRM PROFILE Because we care about your well-being, we designed this space to make ourselves better known, and to highlight the importance and the pharmaco-economic scope of the generic drug. BEKER Laboratories were born from the desire to create a pharmaceutical laboratory of excellence inAlgeria, able to develop, produce and market pharmaceutical products that meet international standards. With the expertise of our pharmaceutical development teams, we develop all our products internally, within our research and development laboratories. We thus totally control the quality of our products. The technological independence that our know- how confers on us, allows us to continually develop and make available to the patients generic products of molecule of last generation, of quality at competitive prices. We are therefore proud to ensure the availability of quality medicines for all. A section, “CONTACT” has been specially designed to receive your comments and / or questions, which we strongly encourage you to consult. We will treat them with a lot of interest, in order to be constantly aware of your needs, to serve you better. We thank you for the interest you place in our laboratory and the trust you place in our products. The Laboratories BEKER were created in 2004 by the emergence of the first site in Dar el Beida. Entity under Algerian law, they respond to the political will of the government which has prioritized the local production of pharmaceuticals to reduce health expenditure, ensuring the availability of quality drugs for all. Currently, we are specialized in the development, manufacturing and marketing of high quality dry generic pharmaceutical products (Tablets, Capsules, Powders) of various therapeutic classes. The success of BEKER Laboratories , despite their young age, is based on the experience of their founders in North America, a qualified human resource and a favorable economic and regulatory environment for the development of the pharmaceutical sector. Thus, we do not stop at the production of drugs whose patents have fallen in the public domain, but also, thanks to our Research and Development (R & D) laboratory, we specialize in the manufacture of drug-based products. natural, to which would be added other projects resulting from the latest technologies of use, which we invite you to discover under the heading “OUR AMBITIONS”. Our R & D, Analysis and Quality Control centers are true hubs of knowledge that, beyond their function, aim at training and sharing valuable knowledge. Also, we work to keep the link with the academic world and thus count on our teams of university researchers of high level. ABOUT BOB VAN DIJK Beker recently received worldwide attention for developing a generic version of Gilead’s Sovaldi, a treatment for hepatitis C. Beker Laboratoires specialises in the development, production and marketing of generic pharmaceutical products in tablet and capsule form that meet international standards. They have over one hundred products spanning several therapeutic areas and infectious diseases. www.bekerlaboratoires.com